P Desjeux

Summary

Affiliation: World Health Organization
Country: Switzerland

Publications

  1. ncbi request reprint Leishmania/HIV co-infections: epidemiology in Europe
    P Desjeux
    Strategy Development and Monitoring of Zoonoses, Foodborne Diseases and Kinetoplastidae, Department of Control, Prevention and Eradication ZFK CPE, World Health Organization, 20 Avenue Appia, CH 1211 Geneva 27, Switzerland
    Ann Trop Med Parasitol 97:3-15. 2003
  2. ncbi request reprint Leishmaniasis: current situation and new perspectives
    P Desjeux
    Department of Control, Prevention and Elimination CDS CPE, Cluster of Communicable Diseases, World Health Organization WHO, Avenue Appia, 1211 Geneva 27, Switzerland
    Comp Immunol Microbiol Infect Dis 27:305-18. 2004
  3. pmc Treatment of Mediterranean visceral leishmaniasis
    L Gradoni
    Laboratorio di Parassitologia, , Rome, Italy
    Bull World Health Organ 73:191-7. 1995
  4. ncbi request reprint The increase in risk factors for leishmaniasis worldwide
    P Desjeux
    Communicable Diseases Surveillance and Response, Epidemic Disease Control, World Health Organization, Geneva, Switzerland
    Trans R Soc Trop Med Hyg 95:239-43. 2001
  5. ncbi request reprint Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia
    H Bermudez
    Faculty of Medicine, Universidad Mayor San Simon, P O Box 4866, Cochabamba, Bolivia
    Ann Trop Med Parasitol 100:591-600. 2006
  6. ncbi request reprint [Therapeutic options for visceral leishmaniasis]
    P Desjeux
    Institute for Oneworld Health iOWH, 899, rue Jean de Gingins, 01220 Divonne, France
    Med Mal Infect 35:S74-6. 2005
  7. ncbi request reprint Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 97:350-4. 2003
  8. ncbi request reprint Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trop Med Int Health 9:724-9. 2004
  9. ncbi request reprint Treatment of cutaneous leishmaniasis among travellers
    J Blum
    Swiss Tropical Institute, Socinstrasse 57, 4002 Basel, Switzerland
    J Antimicrob Chemother 53:158-66. 2004
  10. pmc Parasitic diseases and urban development
    K E Mott
    Division of Control of Tropical Diseases, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 68:691-8. 1990

Collaborators

Detail Information

Publications16

  1. ncbi request reprint Leishmania/HIV co-infections: epidemiology in Europe
    P Desjeux
    Strategy Development and Monitoring of Zoonoses, Foodborne Diseases and Kinetoplastidae, Department of Control, Prevention and Eradication ZFK CPE, World Health Organization, 20 Avenue Appia, CH 1211 Geneva 27, Switzerland
    Ann Trop Med Parasitol 97:3-15. 2003
    ..The parasites and HIV may also be transmitted as the result of needle-sharing among intravenous-drug users...
  2. ncbi request reprint Leishmaniasis: current situation and new perspectives
    P Desjeux
    Department of Control, Prevention and Elimination CDS CPE, Cluster of Communicable Diseases, World Health Organization WHO, Avenue Appia, 1211 Geneva 27, Switzerland
    Comp Immunol Microbiol Infect Dis 27:305-18. 2004
    ..The newly available control tools should allow a scaling up of control activities in priority areas. In anthroponotic foci, the feasibility of getting a strong impact on mortality, morbidity and transmission, is high...
  3. pmc Treatment of Mediterranean visceral leishmaniasis
    L Gradoni
    Laboratorio di Parassitologia, , Rome, Italy
    Bull World Health Organ 73:191-7. 1995
    ....
  4. ncbi request reprint The increase in risk factors for leishmaniasis worldwide
    P Desjeux
    Communicable Diseases Surveillance and Response, Epidemic Disease Control, World Health Organization, Geneva, Switzerland
    Trans R Soc Trop Med Hyg 95:239-43. 2001
    ..While some risk factors are related to a specific eco-epidemiological entity, others affect all forms of leishmaniasis. Risk factors are reviewed here entity by entity...
  5. ncbi request reprint Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia
    H Bermudez
    Faculty of Medicine, Universidad Mayor San Simon, P O Box 4866, Cochabamba, Bolivia
    Ann Trop Med Parasitol 100:591-600. 2006
    ..Being several times cheaper than Glucantime, it could contribute to improving the access of CL and ML patients to treatment, not only in Bolivia but also in other countries of Latin America...
  6. ncbi request reprint [Therapeutic options for visceral leishmaniasis]
    P Desjeux
    Institute for Oneworld Health iOWH, 899, rue Jean de Gingins, 01220 Divonne, France
    Med Mal Infect 35:S74-6. 2005
  7. ncbi request reprint Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trans R Soc Trop Med Hyg 97:350-4. 2003
    ..These findings indicate that the spread of resistance to antimonials is already taking place in Nepal and that a policy to control further spread should be urgently implemented...
  8. ncbi request reprint Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal
    S Rijal
    B P Koirala Institute of Health Sciences, Dharan, Nepal
    Trop Med Int Health 9:724-9. 2004
    ....
  9. ncbi request reprint Treatment of cutaneous leishmaniasis among travellers
    J Blum
    Swiss Tropical Institute, Socinstrasse 57, 4002 Basel, Switzerland
    J Antimicrob Chemother 53:158-66. 2004
    ..An overview of published treatment options and a treatment recommendation is given for each of the most important species. The level of evidence of the studies leading to these recommendations is given...
  10. pmc Parasitic diseases and urban development
    K E Mott
    Division of Control of Tropical Diseases, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 68:691-8. 1990
    ..As the urban health services must deal with the rise in parasitic diseases, appropriate control strategies for the urban setting must be developed and implemented...
  11. ncbi request reprint Prospective evaluation and comparison of the direct agglutination test and an rK39-antigen-based dipstick test for the diagnosis of suspected kala-azar in Nepal
    F Chappuis
    Department of Community Medicine, Geneva University Hospital, Geneva, Switzerland
    Trop Med Int Health 8:277-85. 2003
    ..The rK39 dipstick is cheaper and easier to use than the DAT and could be used widely provided that both its performance and production remain stable...
  12. ncbi request reprint Emerging Leishmania/HIV co-infection in Africa
    D Wolday
    Ethio-Netherlands AIDS Research Project at the Ethiopian Health and Nutrition Research Institute, Addis Ababa
    Med Microbiol Immunol 190:65-7. 2001
    ..Moreover, the number of cases of co-infection is expected to rise in Africa owing to the simultaneous spread of the two infectious diseases and their increasingly overlapping geographical distribution...
  13. ncbi request reprint [Co-infections of leishmania/HIV in south Europe]
    P Desjeux
    , , , Suisse
    Med Trop (Mars) 61:187-93. 2001
    ..The risk of co-infected patients, as carriers of Leishmania in the blood, to be a source of infection for the sandfly, has been recently confirmed. Moreover intravenous drug users also transmit the disease through the sharing of needles...
  14. pmc Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis
    M Boelaert
    Unit of Epidemiology, Institute of Tropical Medicine, Antwerp, Belgium
    Bull World Health Organ 77:667-74. 1999
    ..The use of a sensitive serological test such as the DAT is recommended as the basis of test-treatment strategies for visceral leishmaniasis in areas where the disease is endemic...
  15. pmc New geographical approaches to control of some parasitic zoonoses
    K E Mott
    Division of Control of Tropical Diseases, World Health Organization, Geneva, Switzerland
    Bull World Health Organ 73:247-57. 1995
    ..Geographical information systems (GIS) open a completely new perspective for intersectoral collaboration in adapting new technology to promote control of these diseases...
  16. ncbi request reprint Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent
    M Boelaert
    Epidemiology and Disease Control Unit, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerp, Belgium
    Trans R Soc Trop Med Hyg 102:32-40. 2008
    ..FD-DAT and rK39 can be recommended for clinical practice on the Indian subcontinent. In East Africa, their clinical use should be carefully monitored. More work is needed to improve existing formats, and to develop better VL diagnostics...